Added to YB: 2024-07-16
Pitch date: 2024-07-13
TIL [bullish]
Instil Bio, Inc.
-14.46%
current return
Author Info
Raging Bull Investments is a lawyer by background who shares actionable investment ideas on value opportunities with a catalyst. Sign up for the newsletter.
Company Info
Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies.
Market Cap
$150.2M
Pitch Price
$13.00
Price Target
28.39 (+162%)
Dividend
N/A
EV/EBITDA
-2.11
P/E
-1.99
EV/Sales
N/A
Sector
Biotechnology
Category
special_situation
Revisiting An Old Idea - Instil Bio, Inc.
TIL: AstraZeneca 15yr lease ($7.52M/yr, 3% escalator) for Tarzana property. Valuation ~$120M (5.5% cap). NAV $28.39/sh. CEO owns 35%. Likely near-term sale, adding 40% cash to mkt cap. Risks: cash burn ($10M/qtr), mgmt's poor track record. BML Partners 5.3% stake. Upside: property sale, potential reverse merger.
Read full article (6 min)